Provider profile
Curia.
Biologics CDMOs
Curia describes mammalian cell line and process development and GMP drug substance manufacturing of antibodies, proteins, vaccines and mRNA at Hopkinton, MA, and formulation development and sterile fill-finish (liquid and lyophilized) for biologics and small molecules at Camarillo, CA, Glasgow and, for commercial supply, Albuquerque, NM. It also runs small-molecule services outside this profile. It was formerly AMRI.
- Website
- curiaglobal.com (opens in a new tab)
- Sources reviewed
- November 4, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Analytical development and QC testing1Stated alongside biologics downstream process development
- Cell line development7
- Formulation development6Drug product formulation development within the sterile drug product network (large and small molecules)
- GMP drug product manufacturing6Sterile fill-finish network (Camarillo/Thousand Oaks, Glasgow, Albuquerque) serves small molecules and biologics, including proteins and monoclonal antibodies
- GMP drug substance manufacturing5,8Mammalian drug substance manufacturing at the Hopkinton, MA facility
- Lyophilization9Stated for clinical sterile drug product manufacturing
- Process development1,4
- Stability studies3Stated as shelf-life stability studies within drug product formulation development
- Technology transfer2Stated for sterile drug product process development
Development experience
Development experience
Development stage
- Commercial10Stated for commercial sterile drug product manufacturing (Albuquerque, NM)
- Phase 12Stated for sterile drug product (first in human through commercial manufacturing)
- Phase 26Listed as clinical supply from preclinical to Phase III for the Camarillo/Thousand Oaks and Glasgow drug product sites
- Phase 36Stated for sterile drug product clinical supply (pre-clinical to Phase III)
- Preclinical6Stated for sterile fill-finish (drug product)
Locations
Locations
- Albany, United States · Headquarters11The facilities page labels both Albany, NY (West Campus and Corporate) and Raleigh, NC as Corporate Headquarters
- Glasgow, United Kingdom · Manufacturing site11Clinical sterile drug product (vials, liquid and lyophilized) including mAbs and ADCs
- Albuquerque, United States · Manufacturing site11Commercial sterile drug product (vials, syringes, cartridges) for biologics and small molecules
- Camarillo, United States · Manufacturing site11Clinical sterile drug product (fill-finish, liquid and lyophilized) for proteins, peptides and mAbs as well as small molecules
- Hayward, United States · Laboratory11Biologics discovery; collaborates with Hopkinton on process development
- Hopkinton, United States · Manufacturing site11Biologics cell line and process development and GMP drug substance manufacturing (antibodies, proteins, vaccines, mRNA)
- Raleigh, United States · Office11Also labelled Corporate Headquarters on the facilities page
- Thousand Oaks, United States · Laboratory11Drug product development; grouped with Camarillo as a clinical sterile drug product location
Quality and regulatory
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Available capacity, slot timing and scale for your next campaign
- Recent experience with your specific modality and expression system or chemistry
- Regulatory inspection history of the specific site that would manufacture your product
- Technology-transfer approach, timeline and who owns the resulting process knowledge
- Analytical and QC release testing done in-house versus subcontracted
- Quality agreement terms, batch-failure responsibility and change-order mechanics
Evidence and sources
Evidence and sources
- 1Downstream Process Development | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Process Development | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Formulation Development | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Biologics Upstream Process Development (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5GMP Mammalian Manufacturing (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Sterile Drug Product (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7Biologics (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8GMP mRNA Manufacturing | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Clinical Manufacturing | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 10Commercial Manufacturing | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 11Facilities | Curia (opens in a new tab)Curia · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.